V

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX)

13 employees

Virpax is developing differentiated treatment options that address unmet needs in three multi-billion-dollar markets

Basic info

pharmaceutical manufacturing

antivirals

Neurological

psychological

Psychology

Epilepsy

Pain Management

Cancer Pain

Marketing

Neuroscience

Respiratory Infection

Market Research

Product Research

Acute Pain

Arthroplasty

Pharmaceutical

CNS Disorders

Chronic Pain Mainagement

PTSD

Osteoarthritis pain

Health Care

Post Operative Pain Management

Non-addictive

Biopharma

Surgical Pain

Nanotechnology

Life Science

2017